Guideline Central Blog

Alerts

Guidelines Spotlight ACP Diabetes Guidelines

New 2024 ACP Diabetes Guidelines and the Removal of DPP4s – Guidelines Spotlight

The American College of Physicians (ACP) released a new clinical guideline on April 19, 2024, for Newer Pharmacologic Treatments in Adults With Type 2 Diabetes. This guideline focused specifically on three classes of medications commonly used for patients with Type 2 Diabetes Mellitus: While the guideline is relatively short, consisting of only three key recommendations, […]

Healthcare News & Research - May 2024

Healthcare News & Research – May 2024

Welcome to our succinct summaries of the most recent healthcare news and research. Keep yourself informed with our easily digestible updates sourced from medical media and news outlets. Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men: Individual Participant Data Meta-analyses Study Details | Source Consumption of Olive […]

Guidelines+ Trials Rundown Schizophrenia in Adults

Schizophrenia in Adults – Guidelines+ Trials Rundown

Today we’re going to look at the ongoing studies and clinical trials specific to management of schizophrenia in adults, including in acutely psychotic people with schizophrenia and relapse prevention. The below list was curated by assessing the ongoing Phase 3 trials for migraine treatments, specific for adults, and based in the United States. The dates […]

Guidelines Spotlight ACCAHA Peripheral Artery Disease (PAD)

New Lower Extremity Peripheral Artery Disease Guidelines 2024 – What’s Changed and Key Takeaways

The 2024 AHA/ACC Guideline on the Management of Lower Extremity Peripheral Artery Disease has been officially released today. This new guideline serves as an update to the previous “2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease,” incorporating the latest evidence to assist clinicians in providing comprehensive care for patients […]

Dermatology: Guidelines + Journal Rundown (May 2024)

Dermatology Guidelines+ Journals Rundown (May 2024)

In this post, we will be taking a closer look at some of the most popular dermatology-related articles recently published across leading medical journals. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data Oral Minoxidil vs Topical Minoxidil for […]

Guidelines Side-By-Side Hepatocellular Carcinoma

Comparing Five Current Hepatocellular Carcinoma Clinical Guidelines – Guidelines Side- By-Side Series

For the next installment of our Guidelines Side-By-Side series, we’re going to take a look at the current guidelines for liver cancer. This article will examine how the recommendations in each guideline agree, contradict, or otherwise differ.  Our topic for today will be systemic treatment for metastatic hepatocellular carcinoma. The focus will be limited to […]

Upcoming FDA Decisions – May 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug or device applications. Below, you will find a list of drugs and devices, […]

Guidelines+ Journal Rundown Endocrinology

Endocrinology Guidelines+ Journal Rundown (April 2024)

In this post, we will be taking a closer look at some of the most popular endocrinology-related articles that have been published during the month of April 2024. The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report 2024 Abridged Diabetes Standards of Care Impact of insulin sensitization […]

New FDA Medication Approval – Anktiva for NMIBC

On April 22, 2024, the US Food and Drug Administration (FDA) approved ImmunityBio’s first-in-class interleukin-15 superagonist (IL-15) nogapendekin alfa inbakicept-pmln (Anktiva), plus bacillus Calmette-Guérin (BCG), for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.  Designated an FDA Breakthrough Therapy, the novel immunotherapy […]

Clinical Guideline Alerts & FDA Drug Approvals Hero Image

New Clinical Practice Guidelines & FDA Drug Approvals – September 2023

Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia Author:American College of Obstetricians and Gynecologists (ACOG) Published:September 1, 2023 Outpatient Treatment of Confirmed COVID-19 Author:American College of Physicians (ACP) Published:September 19, 2023 Optimal Timing of Elective Hip or Knee Arthroplasty for Patients with Symptomatic Moderate to Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis with Secondary Arthritis […]

Clinical Guideline Alerts Banner

New Clinical Practice Guidelines & FDA Drug Approvals – August 2023

Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication Author:United States Preventive Services Task Force (USPSTF) Published:August 2023 Prevention of Acquisition of HIV: Preexposure Prophylaxis Author:United States Preventive Services Task Force (USPSTF) Published:August 2023 Palliative Care for People with Chronic Obstructive Pulmonary Disease or Interstitial Lung Disease Author:European Respiratory Society (ERS) Published:August 17, 2023 […]

New Clinical Practice Guidelines & FDA Drug Approvals – July 2023

Lipid Disorders in Children and Adolescents: Screening Author:United States Preventive Services Task Force (USPSTF) Published:July 2023 Implementing Strategies to Prevent Infections in Acute-Care Settings Author:Infectious Diseases Society of America (IDSA); Society for Healthcare Epidemiology of America America (SHEA) Published:July 11, 2023 Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy Author:American Society of Clinical Oncology (ASCO) […]

New Clinical Practice Guidelines & FDA Drug Approvals – June 2023

Anxiety Disorders in Adults: Screening – Adults 64 Years or Younger Author:United States Preventive Services Task Force (USPSTF) Published:June 2023 Anxiety Disorders in Adults: Screening – Older Adults 65 Years or Older Author:United States Preventive Services Task Force (USPSTF) Published:June 2023 Depression and Suicide Risk in Adults: Screening – Adults 64 Years or Younger Author:United […]

New Clinical Practice Guidelines & FDA Drug Approvals – May 2023

Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity Society:American Association of Clinical Endocrinologists (AACE) Published:May 4, 2023 Health Advisory on Social Media Use in Adolescence Society:American Psychological Association (APA) Published:May 9, 2023 2023 Comprehensive Type 2 Diabetes Management […]

New Clinical Guidelines & FDA Drug Approvals – April 2023

Skin Cancer: Screening Society:U.S. Preventative Services Task Foce (USPSTF) Published:April 18, 2023 COVID-19 Guideline Part 1: Treatment and Management Society:Infectious Diseases Society of America (IDSA) Published:April 13, 2023 Use of Antiretroviral Agents in Pediatric HIV Infection Society:United States Department of Health and Human Services (DHHS) Published:April 12, 2023 Management of REM Sleep Behavior Disorder Society:American […]

Clinical Guidelines Alert March 2023 Hero Image

New Clinical Guidelines & FDA Drug Approvals – March 2023

Probiotics and Prebiotics Society:World Gastroenterology Organisation (WGO) Published:March 1, 2023 Obesity Algorithm 2023 Society:Obesity Medicine Association (OMA) Published:March 1, 2023 Colorectal Cancer Screening Guidelines Toolkit Society:Consensus and Physician Experts (CPE) Published:March 1, 2023 COVID-19 Guideline, Part 1: Treatment and Management Society:Infectious Diseases Society of America (IDSA) Published:March 14, 2023 Comprehensive Adult Eye and Vision Examination […]

New Clinical Guidelines & FDA Drug Approvals – February 2023

Genital Herpes Infection: Serologic Screening Society:U.S. Preventive Services Task Force (USPSTF) Published:February 2023 Management of Patients With Acute Lower Gastrointestinal Bleeding Society:American College of Gastroenterology (ACG) Published:February 6, 2023 Strategies to Prevent Healthcare-Associated Infections: Hand Hygiene Society:Infectious Diseases Society of America (IDSA); Society for Healthcare Epidemiology of America (SHEA) Published:February 8, 2023 Disorders of Lipid […]

New Clinical Guidelines & FDA Drug Approvals – January 2023

Immunotherapy & Targeted Therapy for Advanced Gastroesophageal Cancer Society:American Society of Clinical Oncology (ASCO) Published:January 5, 2023 Vaccinations in Patients with Rheumatic & Musculoskeletal Diseases Society: American College of Rheumatology (ACR) Published:January 4, 2023 Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults Society:American College of Physicians (ACP) Published:January 3, […]